Primary Site >> Stomach Cancer

Gene >> LOXL2

Journal: Carcinogenesis. 2009 Oct;30(10):1660-9.
Title: Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
Author: Peng, Liang|Ran, Yu-Liang|Hu, Hai|Yu, Long|Liu, Qian|Zhou, Zhuan|Sun, Yue-Min|Sun, Li-Chao|Pan, Jian|Sun, Li-Xin|Zhao, Ping|Yang, Zhi-Hua
PMID: 19625348
Journal: FASEB J. 2011 Jan;25(1):55-65.
Title: Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2.
Author: Brekhman, Vera|Lugassie, Jennie|Zaffryar-Eilot, Shelly|Sabo, Edmond|Kessler, Ofra|Smith, Victoria|Golding, Hana|Neufeld, Gera
PMID: 20802105
Journal: Cancer Lett. 2014 Nov 28;354(2):438-46.
Title: Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer.
Author: Kasashima, Hiroaki|Yashiro, Masakazu|Kinoshita, Haruhito|Fukuoka, Tatsunari|Morisaki, Tamami|Masuda, Go|Sakurai, Katsunobu|Kubo, Naoshi|Ohira, Masaichi|Hirakawa, Kosei
PMID: 25128648
Journal: Bioorg Med Chem Lett. 2018 Oct 1;28(18):3113-3118.
Title: Inhibition of the LOX enzyme family members with old and new ligands. Selectivity analysis revisited.
Author: Hajdu, Istvan|Kardos, Jozsef|Major, Balazs|Fabo, Gabriella|Lorincz, Zsolt|Cseh, Sandor|Dorman, Gyorgy
PMID: 30098867